Header image

Please note: Programme is subject to change and speaker names will be added/updated over the coming weeks.


AstraZeneca has provided sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence, except for the AstraZeneca sponsored symposia presentations


Saturday, April 27, 2024

Track 1
Track 2
9:00 AM - 3:00 PM Registration Open - Saturday Workshops Only
9:30 AM - 10:20 AM
9:50 AM - 12:30 PM Haematology Essentials Session 1
10:20 AM - 10:50 AM
10:30 AM - 12:30 PM Pitfalls in Genomics Session 1
10:50 AM - 11:35 AM
11:35 AM - 12:35 PM
12:30 PM - 1:15 PM Haematology Essentials: Lunch
12:30 PM - 1:30 PM Pitfalls in Genomics Lunch & Networking
12:35 PM - 1:35 PM
1:15 PM - 3:35 PM Haematology Essentials Session 2
1:30 PM - 3:30 PM Pitfalls in Genomics Session 2
1:35 PM - 2:35 PM
2:35 PM - 3:20 PM
3:00 PM - 7:30 PM Registration Open - All attending BSH 2024
3:20 PM - 3:55 PM
3:30 PM - 4:00 PM Pitfalls in Genomics Refreshment Break
3:35 PM - 3:55 PM Haematology Essentials: Refreshments
3:55 PM - 4:45 PM
3:55 PM - 5:50 PM Haematology Essentials Session 3
4:00 PM - 6:00 PM Pitfalls in Genomics Session 3
4:45 PM - 6:00 PM
6:00 PM - 7:30 PM Welcome Reception

Track 3
9:00 AM - 3:00 PM Registration Open - Saturday Workshops Only
9:30 AM - 10:20 AM BSH/EHA YoungEHA Research Meeting 2024 Opening Talk
9:50 AM - 12:30 PM
10:20 AM - 10:50 AM BSH/EHA YoungEHA Research Meeting 2024 Session 1
10:30 AM - 12:30 PM
10:50 AM - 11:35 AM BSH/EHA YoungEHA Research Meeting 2024: Refreshments
11:35 AM - 12:35 PM BSH/EHA YoungEHA Research Meeting 2024 Session 2
12:30 PM - 1:15 PM
12:30 PM - 1:30 PM
12:35 PM - 1:35 PM BSH/EHA YoungEHA Research Meeting 2024: Lunch
1:15 PM - 3:35 PM
1:30 PM - 3:30 PM
1:35 PM - 2:35 PM BSH/EHA YoungEHA Research Meeting 2024 Session 3
2:35 PM - 3:20 PM BSH/EHA YoungEHA Research Meeting 2024 - Refreshments
3:00 PM - 7:30 PM Registration Open - All attending BSH 2024
3:20 PM - 3:55 PM BSH/EHA YoungEHA Research Meeting 2024 Session 4
3:30 PM - 4:00 PM
3:35 PM - 3:55 PM
3:55 PM - 4:45 PM BSH/EHA YoungEHA Research Meeting 2024 - Closing Talk
3:55 PM - 5:50 PM
4:00 PM - 6:00 PM
4:45 PM - 6:00 PM BSH/EHA YoungEHA Research Meeting 2024 Poster Viewing
6:00 PM - 7:30 PM Welcome Reception

Track 1
9:00 AM - 3:00 PM Registration Open - Saturday Workshops Only
9:30 AM - 10:20 AM
9:50 AM - 12:30 PM
10:20 AM - 10:50 AM
10:30 AM - 12:30 PM Pitfalls in Genomics Session 1
10:50 AM - 11:35 AM
11:35 AM - 12:35 PM
12:30 PM - 1:15 PM
12:30 PM - 1:30 PM Pitfalls in Genomics Lunch & Networking
12:35 PM - 1:35 PM
1:15 PM - 3:35 PM
1:30 PM - 3:30 PM Pitfalls in Genomics Session 2
1:35 PM - 2:35 PM
2:35 PM - 3:20 PM
3:00 PM - 7:30 PM Registration Open - All attending BSH 2024
3:20 PM - 3:55 PM
3:30 PM - 4:00 PM Pitfalls in Genomics Refreshment Break
3:35 PM - 3:55 PM
3:55 PM - 4:45 PM
3:55 PM - 5:50 PM
4:00 PM - 6:00 PM Pitfalls in Genomics Session 3
4:45 PM - 6:00 PM
6:00 PM - 7:30 PM Welcome Reception

Track 2
9:00 AM - 3:00 PM Registration Open - Saturday Workshops Only
9:30 AM - 10:20 AM
9:50 AM - 12:30 PM Haematology Essentials Session 1
10:20 AM - 10:50 AM
10:30 AM - 12:30 PM
10:50 AM - 11:35 AM
11:35 AM - 12:35 PM
12:30 PM - 1:15 PM Haematology Essentials: Lunch
12:30 PM - 1:30 PM
12:35 PM - 1:35 PM
1:15 PM - 3:35 PM Haematology Essentials Session 2
1:30 PM - 3:30 PM
1:35 PM - 2:35 PM
2:35 PM - 3:20 PM
3:00 PM - 7:30 PM Registration Open - All attending BSH 2024
3:20 PM - 3:55 PM
3:30 PM - 4:00 PM
3:35 PM - 3:55 PM Haematology Essentials: Refreshments
3:55 PM - 4:45 PM
3:55 PM - 5:50 PM Haematology Essentials Session 3
4:00 PM - 6:00 PM
4:45 PM - 6:00 PM
6:00 PM - 7:30 PM Welcome Reception

Track 3
9:00 AM - 3:00 PM Registration Open - Saturday Workshops Only
9:30 AM - 10:20 AM BSH/EHA YoungEHA Research Meeting 2024 Opening Talk
9:50 AM - 12:30 PM
10:20 AM - 10:50 AM BSH/EHA YoungEHA Research Meeting 2024 Session 1
10:30 AM - 12:30 PM
10:50 AM - 11:35 AM BSH/EHA YoungEHA Research Meeting 2024: Refreshments
11:35 AM - 12:35 PM BSH/EHA YoungEHA Research Meeting 2024 Session 2
12:30 PM - 1:15 PM
12:30 PM - 1:30 PM
12:35 PM - 1:35 PM BSH/EHA YoungEHA Research Meeting 2024: Lunch
1:15 PM - 3:35 PM
1:30 PM - 3:30 PM
1:35 PM - 2:35 PM BSH/EHA YoungEHA Research Meeting 2024 Session 3
2:35 PM - 3:20 PM BSH/EHA YoungEHA Research Meeting 2024 - Refreshments
3:00 PM - 7:30 PM Registration Open - All attending BSH 2024
3:20 PM - 3:55 PM BSH/EHA YoungEHA Research Meeting 2024 Session 4
3:30 PM - 4:00 PM
3:35 PM - 3:55 PM
3:55 PM - 4:45 PM BSH/EHA YoungEHA Research Meeting 2024 - Closing Talk
3:55 PM - 5:50 PM
4:00 PM - 6:00 PM
4:45 PM - 6:00 PM BSH/EHA YoungEHA Research Meeting 2024 Poster Viewing
6:00 PM - 7:30 PM Welcome Reception


Sunday, April 28, 2024

Track 1
Track 2
Track 3
Track 4
Track 5
9:30 AM - 7:00 PM Registration Open - Sunday
10:00 AM - 10:30 AM Sunday Morning Coffee & Networking Break
10:30 AM - 11:15 AM Welcome Address & Awards Ceremony
11:15 AM - 12:30 PM BSH & ASH Session
12:30 PM - 1:20 PM Industry Educational Session - Implementing Novel Agents in RRMM in current practice - Sponsored by Pfizer
12:30 PM - 2:15 PM Sunday Lunch & Networking
12:35 PM - 1:20 PM Industry Educational Session - Improving iMCD Diagnosis and Outcomes: The role of Sylvant - Sponsored by Recordati Rare Disease Industry Educational session - Now is the time: How to optimise the delivery of care for patients with haemoglobinopathies in the UK - Sponsored by Vertex
12:45 PM - 2:15 PM HaemSTAR & UK-TReN
1:00 PM - 2:00 PM Meet the Expert - Transfusion and supportive care Meet the Expert - Challenges in diagnosis of haemostatic and thrombotic disorders Meet the Nursing Expert - Transplant and beyond
1:25 PM - 2:10 PM Industry Educational Session - Hear from Prof B. Inusa, Dr K. Gardner & Dr M. Besser as they discuss the treatment of haemolytic anaemia in sickle cell disease. This is a promotional symposium sponsored and funded by Pfizer Ltd. Industry Educational session - Tailor treatment in CLL: learn how to optimise patient outcomes and shape the future of CLL patient management - Sponsored by Janssen Industry Educational session - Blood Cancer Dialogues: Navigating Doctor-Patient Communication around Unexpected Diagnoses. GSK: Non-promotional symposium Industry educational Session - When does MRD has a clinical impact for MM and CLL patients? - Sponsored by Adaptive Biotechnologies
2:15 PM - 3:45 PM A multidisciplinary approach to research Nursing in the post transplant era Crucible - What is the greatest threat to the future of haematology? Advances in Paediatric Haematology Top Abstracts with Expert Perspective: Thrombosis and Haemostasis
3:50 PM - 4:35 PM MacFarlane-Biggs Plenary Lecture
4:35 PM - 5:20 PM Sunday Afternoon Coffee & Networking Break
4:40 PM - 5:10 PM Industry educaional Session - The role of geriatric assessment when determining treatment in older patients with newly diagnosed AML - Sponsored by Abbvie
5:20 PM - 6:50 PM The evolving landscape of haematology training: from undergraduate to specialist Transplant What is new in anticoagulation? Expanding Strategies for Enhancing Health and Well-Being: Diversifying Our Approach. Top Abstracts with Expert Perspective: General Haematology including ITP and Myeloproliferative Disorders
8:00 PM - 11:59 PM BSH 2024 Social Evening



Track 1
9:30 AM - 7:00 PM Registration Open - Sunday
10:00 AM - 10:30 AM Sunday Morning Coffee & Networking Break
10:30 AM - 11:15 AM Welcome Address & Awards Ceremony
11:15 AM - 12:30 PM BSH & ASH Session
12:30 PM - 1:20 PM
12:30 PM - 2:15 PM Sunday Lunch & Networking
12:35 PM - 1:20 PM
12:45 PM - 2:15 PM HaemSTAR & UK-TReN
1:00 PM - 2:00 PM Meet the Expert - Transfusion and supportive care
1:25 PM - 2:10 PM
2:15 PM - 3:45 PM A multidisciplinary approach to research
3:50 PM - 4:35 PM MacFarlane-Biggs Plenary Lecture
4:35 PM - 5:20 PM Sunday Afternoon Coffee & Networking Break
4:40 PM - 5:10 PM
5:20 PM - 6:50 PM The evolving landscape of haematology training: from undergraduate to specialist
8:00 PM - 11:59 PM BSH 2024 Social Evening






Monday, April 29, 2024

Track 1
Track 2
Track 3
Track 4
Track 5
Track 6
6:45 AM - 7:15 PM Registration Open - Monday
7:00 AM - 8:00 AM Meet the Editor – British Journal of Haematology Meet the Expert - Emerging role of Obstetric haematology in maternal medicine networks Meet the Expert - Managing challenging MPN cases: what do we have now and what is on the horizon? Meet the Experts - Workforce in uncertain times Morning Yoga with Megan
7:30 AM - 8:00 AM Monday Early Morning Coffee & Networking Break
8:00 AM - 9:30 AM Autoimmune Haematology How is the management paradigm evolving for patients with B-cell ALL in 2024? Top Abstracts with Expert Perspective: Lymphoma BSH Early Career’s Forum Round Table Discussion - “Future of Haematology: The Importance of Mentorship” Areas of uncertainty in transfusion medicine Rethinking healthcare to improve sustainability and patient outcomes
9:35 AM - 11:05 AM Laboratory Haematology - stepping into the future Obstetric Lymphoma Special Interest Group BSH & British Cardio-Oncology Society Top Abstracts with Expert Perspective: Transplantation, Gene and Cellular Immunotherapies BSH Guidelines
11:05 AM - 11:45 AM Monday Morning Coffee & Networking Break
11:10 AM - 11:40 AM Industry Educational Session - Navigating the changing landscape in diffuse large B-cell lymphoma  (Gilead products will be discussed in this symposium) - Sponsored by Gilead Industry Educational Session - Abbvie promotional panel discussion on treatment sequencing in CLL - Sponsored by Abbvie Industry Educational Session - PNH in the UK: 20 Years of Expertise and Collaboration - Promotional Symposium sponsored by Alexion
11:45 AM - 1:15 PM BSH Medal Lecture and Presidential Session
1:15 PM - 3:00 PM Monday Lunch & Networking
1:25 PM - 2:10 PM Industry Educational and Promotional Session - A spotlight on adult patient cases with t-AML and AML-MRC – multidisciplinary team decision-making explored. A promotional symposium organised and sponsored by Jazz Pharmaceuticals Industry Educational Session - In conversation with Wendy & Will on the practicalities of a treatment delivery in 3L+ DLBCL - Sponsored by Roche Industry Educational Session - Partnering with patients to redefine watch and wait How to discuss active monitoring with your patients – developing a consensus approach in Waldenström's macroglobulinaemia - Sponsored by Beigene Industry Educational Session - Case Based Discussion on Management of Myelofibrosis in Patients with Moderate to Severe Anaemia; GSK Promotional Symposium
2:15 PM - 2:45 PM Industry Educational Session - Navigating the changing treatment landscape of relapsed refractory DLBCL - Sponsored by Sobi
2:15 PM - 3:00 PM Industry Educational Session - How is the evolving Multiple Myeloma therapeutic landscape changing treatment decision making? - Sponsored by Janssen Industry Educational Session - Management of DOAC-related Life-threatening GI Bleeds – Building the Evidence - AstraZeneca Sponsored Promotional Symposium Industry educational session - Psychological impact and healthcare disparities in blood cancer: can we do better? - Sponsored by Pfizer
3:00 PM - 4:30 PM Morphology Cases Teenage and Young Adult (TYA) CAR-T cells – new indications and managing haematotoxicity Optimising Management Strategies for Myeloproliferative Neoplasms in 2024 Top Abstracts with Expert Perspective: Myeloma/CLL Patient Support Groups- whose responsibility is it to support patients?
4:30 PM - 5:00 PM Industry Educational Session - Management of toxicity induced by high-dose methotrexate (HDMTX) in haemato-oncology patients - SERB Pharmaceuticals
4:30 PM - 5:15 PM Monday Afternoon Coffee & Networking Break
Industry Educational Session - Approaches to Polycythaemia Vera: A Clinical Perspective - Sponsored by Novartis Industry Educational Session - AbbVie promotional panel discussion on treatment and management of 3L+ DLBCL - Sponsored by Abbvie Industry Educational Session - Showcasing clinical innovation across the CAR-T pathway: hear about completed and ongoing clinical projects aiming to improve patient care - Sponsored by Gilead
5:15 PM - 6:00 PM Industry Education session - Introducing XPO-1 Inhibition for multiple myeloma, the next step after relapse. - Sponsored by Menarini Stemline
5:15 PM - 6:15 PM Thrombosis prevention around the world
6:15 PM - 7:15 PM Poster Walk

Track 3
Track 4
6:45 AM - 7:15 PM Registration Open - Monday
7:00 AM - 8:00 AM Meet the Expert - Managing challenging MPN cases: what do we have now and what is on the horizon? Meet the Experts - Workforce in uncertain times
7:30 AM - 8:00 AM Monday Early Morning Coffee & Networking Break
8:00 AM - 9:30 AM Top Abstracts with Expert Perspective: Lymphoma BSH Early Career’s Forum Round Table Discussion - “Future of Haematology: The Importance of Mentorship”
9:35 AM - 11:05 AM Lymphoma Special Interest Group BSH & British Cardio-Oncology Society
11:05 AM - 11:45 AM Monday Morning Coffee & Networking Break
11:10 AM - 11:40 AM Industry Educational Session - Navigating the changing landscape in diffuse large B-cell lymphoma  (Gilead products will be discussed in this symposium) - Sponsored by Gilead Industry Educational Session - Abbvie promotional panel discussion on treatment sequencing in CLL - Sponsored by Abbvie
11:45 AM - 1:15 PM BSH Medal Lecture and Presidential Session
1:15 PM - 3:00 PM Monday Lunch & Networking
1:25 PM - 2:10 PM Industry Educational Session - In conversation with Wendy & Will on the practicalities of a treatment delivery in 3L+ DLBCL - Sponsored by Roche Industry Educational Session - Partnering with patients to redefine watch and wait How to discuss active monitoring with your patients – developing a consensus approach in Waldenström's macroglobulinaemia - Sponsored by Beigene
2:15 PM - 2:45 PM
2:15 PM - 3:00 PM Industry Educational Session - How is the evolving Multiple Myeloma therapeutic landscape changing treatment decision making? - Sponsored by Janssen
3:00 PM - 4:30 PM CAR-T cells – new indications and managing haematotoxicity Optimising Management Strategies for Myeloproliferative Neoplasms in 2024
4:30 PM - 5:00 PM
4:30 PM - 5:15 PM Monday Afternoon Coffee & Networking Break
Industry Educational Session - Approaches to Polycythaemia Vera: A Clinical Perspective - Sponsored by Novartis Industry Educational Session - AbbVie promotional panel discussion on treatment and management of 3L+ DLBCL - Sponsored by Abbvie
5:15 PM - 6:00 PM
5:15 PM - 6:15 PM
6:15 PM - 7:15 PM Poster Walk

Track 5
Track 6
6:45 AM - 7:15 PM Registration Open - Monday
7:00 AM - 8:00 AM Morning Yoga with Megan
7:30 AM - 8:00 AM Monday Early Morning Coffee & Networking Break
8:00 AM - 9:30 AM Areas of uncertainty in transfusion medicine Rethinking healthcare to improve sustainability and patient outcomes
9:35 AM - 11:05 AM Top Abstracts with Expert Perspective: Transplantation, Gene and Cellular Immunotherapies BSH Guidelines
11:05 AM - 11:45 AM Monday Morning Coffee & Networking Break
11:10 AM - 11:40 AM Industry Educational Session - PNH in the UK: 20 Years of Expertise and Collaboration - Promotional Symposium sponsored by Alexion
11:45 AM - 1:15 PM BSH Medal Lecture and Presidential Session
1:15 PM - 3:00 PM Monday Lunch & Networking
1:25 PM - 2:10 PM Industry Educational Session - Case Based Discussion on Management of Myelofibrosis in Patients with Moderate to Severe Anaemia; GSK Promotional Symposium
2:15 PM - 2:45 PM
2:15 PM - 3:00 PM Industry Educational Session - Management of DOAC-related Life-threatening GI Bleeds – Building the Evidence - AstraZeneca Sponsored Promotional Symposium Industry educational session - Psychological impact and healthcare disparities in blood cancer: can we do better? - Sponsored by Pfizer
3:00 PM - 4:30 PM Top Abstracts with Expert Perspective: Myeloma/CLL Patient Support Groups- whose responsibility is it to support patients?
4:30 PM - 5:00 PM Industry Educational Session - Management of toxicity induced by high-dose methotrexate (HDMTX) in haemato-oncology patients - SERB Pharmaceuticals
4:30 PM - 5:15 PM Monday Afternoon Coffee & Networking Break
Industry Educational Session - Showcasing clinical innovation across the CAR-T pathway: hear about completed and ongoing clinical projects aiming to improve patient care - Sponsored by Gilead
5:15 PM - 6:00 PM Industry Education session - Introducing XPO-1 Inhibition for multiple myeloma, the next step after relapse. - Sponsored by Menarini Stemline
5:15 PM - 6:15 PM
6:15 PM - 7:15 PM Poster Walk

Track 1
6:45 AM - 7:15 PM Registration Open - Monday
7:00 AM - 8:00 AM Meet the Editor – British Journal of Haematology
7:30 AM - 8:00 AM Monday Early Morning Coffee & Networking Break
8:00 AM - 9:30 AM Autoimmune Haematology
9:35 AM - 11:05 AM Laboratory Haematology - stepping into the future
11:05 AM - 11:45 AM Monday Morning Coffee & Networking Break
11:10 AM - 11:40 AM
11:45 AM - 1:15 PM BSH Medal Lecture and Presidential Session
1:15 PM - 3:00 PM Monday Lunch & Networking
1:25 PM - 2:10 PM
2:15 PM - 2:45 PM
2:15 PM - 3:00 PM
3:00 PM - 4:30 PM Morphology Cases
4:30 PM - 5:00 PM
4:30 PM - 5:15 PM Monday Afternoon Coffee & Networking Break
5:15 PM - 6:00 PM
5:15 PM - 6:15 PM Thrombosis prevention around the world
6:15 PM - 7:15 PM Poster Walk







Tuesday, April 30, 2024

Track 1
Track 2
Track 3
Track 4
Track 5
7:00 AM - 3:45 PM Registration Open - Tuesday
7:15 AM - 8:15 AM Meet the Expert - CAR-T Cell Meet the Expert - Multiple Myeloma Meet the Expert - Who, when and how to transplant in AML Meet the Expert - Managing anaemia in low risk MDS. Now and the future
8:00 AM - 8:30 AM Tuesday Early Morning Coffee & Networking Break
8:30 AM - 10:00 AM Haemato-oncology trials update (NCRI) British Journal of Haematology: Hot Topics in UK Haematology Research CLL and Richter's Syndrome - Current Thinking Exploring global opportunities in haematology training Top Abstracts with Expert Perspective: Red Cell Disorders
10:00 AM - 10:45 AM Tuesday Morning Coffee & Networking Break
10:45 AM - 12:15 PM BSH & EHA Session - Challenges to haematology across geographical Europe
12:15 PM - 1:30 PM Tuesday Lunch & Networking
12:20 PM - 12:55 PM Industry Educational Session - CTCL management from a haematologist’s perspective with update from EORTC 2023 guidelines - Sponsored by Kyowa Kirin
12:20 PM - 1:05 PM Industry Educational Session - Challenging the Standard of Care post 2 TKIs for patients with Ph+ CP-CML: Real World Experience - Sponsored by Novartis Industry Educational Session - Exploring Genomic Signatures in Malignant Lymphoma: Advantages for Early Detection, Treatment, and Monitoring under Research Use Only (RUO) Guidelines - Sponsored by Thermofisher Scientific Industry Educational Session - Dynamics of treatment selection: CLL patient cases discussion - Sponsored by Astrazeneca
1:30 PM - 2:15 PM Sir John Dacie Lecture
2:15 PM - 3:45 PM Advances in the management of acute myeloid leukaemia Top Abstracts with Expert Perspective: Education and Professional UKMRA / UKMS Session: Prognostic risk factors and Bispecific Antibodies for Multiple Myeloma - how to bring them into practice Haemoglobinopathies Top Abstracts with Expert Perspective: Laboratory Haematology and Transfusion









 

loading